Back-to-Back USFDA Approvals Boost Zydus Lifesciences, Shares Hit 8-Month High
Zydus Lifesciences’ drug hit an eight-month high following a string of US regulatory approvals. The stock hit Rs 426 on the NSE on October 7...
Tag : Cipla
Rupee Slips to 79.80 Against USD as Sensex, Nifty50 Dip Sharply on Negative Global Hints
India’s stock benchmark fell on Friday, tracking pessimism in global markets, as data from the world’s largest economy offered little reason to ease the Fed’s...
Nifty50 Down 17,350 Led by Financial, IT and FMCG Shares
India’s stock market benchmark opened lower on Tuesday, the second day of its most significant drop in more than two months, weighed down by weakness...
Sensex, Nifty50 Edge Lower on Weakness In IT, Pharma Stocks
India’s stock market benchmark fell on Thursday, pulling back from a four-month high on weakness in IT, healthcare and oil and gas stocks. Globally, investors...
Sensex Crosses 60,000 Mark for First Time in More Than 4 Months
India’s stock market benchmark opened in the green on Wednesday, with the Sensex breaking the 60,000-point mark in intraday trading for the first time since...
Sensex Up 200 Points, Nifty50 Tops 17,400 Ahead of RBI Policy Announcement
The Indian equity benchmark opened in the green on the last trading day of the trading week ahead of the Reserve Bank of India’s key...
Cipla To Invest Rs 26 Crore in GoApptiv to Raise Stake to 22%
Pharmaceutical company Cipla has agreed to buy an additional stake in digital tech firm GoApptiv Private for nearly Rs 26 crore, raising its stake to...
Cipla to Acquire 21% Stake in Achira Labs for Rs 25 Crore
Pharmaceutical giant Cipla Ltd said on Friday it would buy a 21.05% stake in Achira Labs Pvt Ltd, which develops and commercialises point-of-care (POC) medical...
Cipla Signs Deal with Genes2Me to Launch COVID-19 RT PCR Test Kit
On Tuesday, pharmaceutical giant Cipla said it has partnered with diagnostics firm Genes2Me to launch a COVID-19 RT PCR test kit in the country. In...
Cipla Gets DGCI Permission to Import Moderna’s Vaccine
Cipla, a multinational pharmaceutical company headquartered in Mumbai, on Tuesday received approval from the Drugs Controller General of India (DCGI) to import Moderna’s coronavirus vaccine...